Results 281 to 290 of about 217,331 (294)

Recent Progress in Double Filtration Plasmapheresis

open access: yesHemodialysis International, EarlyView.
ABSTRACT Double‐filtration plasmapheresis is an advanced extracorporeal blood purification technique that selectively removes pathogenic macromolecules based on molecular weight. Unlike conventional plasma exchange, double‐filtration plasmapheresis uses a two‐step filtration process to retain beneficial plasma components such as albumin, while ...
Dan Li   +3 more
wiley   +1 more source

Identification of early predictors of clinical remission in primary membranous nephropathy: a <i>post hoc</i> analysis of the STARMEN trial. [PDF]

open access: yesClin Kidney J
Rojas-Rivera JE   +15 more
europepmc   +1 more source

Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular Carcinoma

open access: yesHepatology Research, EarlyView.
ABSTRACT Background Atezolizumab plus bevacizumab (AB) is a standard first‐line therapy for unresectable hepatocellular carcinoma (HCC). However, data on the efficacy and safety of AB rechallenge (re‐AB) after discontinuation are limited. Methods We conducted a retrospective analysis of 13 patients with unresectable HCC who received initial AB ...
Yuichiro Suzuki   +13 more
wiley   +1 more source

Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA‐CKD and FIGARO‐DKD

open access: yes
Diabetes, Obesity and Metabolism, EarlyView.
Mark André de la Rambelje   +4 more
wiley   +1 more source

Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis

open access: yesHepatology Research, EarlyView.
ABSTRACT Background Hepatocellular carcinoma (HCC) with Vp4 portal vein tumor thrombosis (PVTT) has an extremely poor prognosis, and evidence for effective systemic therapy is limited. Preclinical studies suggest that hypofractionated radiation therapy (HFRT) may enhance immune checkpoint inhibitor (ICI) efficacy through immunogenic cell death and ...
Masahiko Tameda   +11 more
wiley   +1 more source

Serum Factors in Primary Podocytopathies. [PDF]

open access: yesAntibodies (Basel)
Filippone EJ, Farber JL.
europepmc   +1 more source

Kidney and Pregnancy: A Comprehensive Review. [PDF]

open access: yesClin Pract
Piscitani L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy